STOCK TITAN

Praxis Precision Medicines (PRAX) Revenue by Year

PRAX NASDAQ

Praxis Precision Medicines, Inc. generated $0 in revenue in fiscal year 2025. This represents a decrease of 100.0% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Praxis Precision Medicines, Inc. has filed alongside them.

FY2025 annual
Revenue $0
YoY -100.0%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PRAX Revenue by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
Revenue$0-100.0%$8.6M+249.5%$2.4Mn/m$0N/AN/AN/A

PRAX Revenue by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
RevenueN/AN/AN/A$0-100.0%$0-100.0%$0-100.0%$0-100.0%$7.5M+1349.1%$302K-35.5%$357K-54.3%$431K-36.9%$515K

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Praxis Precision Medicines, Inc. financials

Frequently Asked Questions

Praxis Precision Medicines, Inc. generated $0 in revenue in fiscal year 2025.

Praxis Precision Medicines, Inc. (PRAX) revenue fell by 100.0% year over year, from $8.6M to $0 in fiscal year 2025.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Praxis Precision Medicines, Inc. (PRAX) reported on that line in every period on record.